Barbara Nel

Barbara Nel has extensive experience in the pharmaceutical and healthcare sectors, having held senior leadership roles at AstraZeneca from May 2017 to December 2022, including Global Head of Marketing and Country President for the African Cluster. Previous positions at Genzyme involved managing business units in transplantation, oncology, and hematology, along with serving as National Sales Director for chronic kidney disease. Early in the career, Barbara Nel worked at the Chiesi Group as National Hospital Sales Manager for neonatal respiratory care and held roles at sanofi-aventis and Markinor focused on oncology and market research, respectively. Educational qualifications include courses in Managerial Finance from The London School of Economics and Enterprise Leadership from the Massachusetts Institute of Technology.